Sell off coming

[anonymous]

Taking bets.....January or February?

 

[anonymous]

Taking bets.....January or February?

We are in the middle stages of Frenchie's work plan. Deplete cash, sell off products, drive down the stock price, gather millions of dollars in stock options at deflated strike prices and then put the company on the auction block and negotiate a sales price at 25%-30% premium and sell us down the river. He leaves with a golden parachute and can sell his options for millions more and then move on to the next group of suckers dumb enough to hire him.

 

[anonymous]

Bring it on. Sick place

 

[anonymous]

selling respiratory or diabetes is the question

 

[anonymous]

a package deal.....all of it!

 

[anonymous]

Yes, the board of directors and shareholders all got sold a bill of goods. It was the best ,most complete example of poor judgement in the last decade of pharma.
On to the question: yes, and yes.
First: diabetes sold off, because of really nothing in pipeline and who knows if saxa-dapa is in the works. Also empa-reg outcomes data will create flat sales for 2017. Slight 2017 decline in Farxiga revenue, in best case scenario. Will be difficult to grow...I mean what you gonna do..it's free already!!! (OR, ESS laid off first, CV second, 1/3 to 1/2 laid off in rest of diabetes...in that order...as a last resort...)
Second: bye bye respiratory.
Third: AZ will be bought out late 17' with valuation 50% -or LESS - of what Pfizer offered us.
Fourth: by 2018, AZ will only be an afterthought of a once decent blockbuster company.